Skip to main content
  • Clinical
      |Clinical
    • Acute Coronary Syndromes
    • Cardiac Surgery
    • Covid-19
    • Heart Failure
    • Heart Health
    • Heart Rhythm
    • Hypertension
    • Interventional Cardiology
    • Mitral Valve
    • Pharmaceutics
    • Structural Heart Disease
    • TAVR
    • Tricuspid Valve
    • Vascular & Endovascular
  • Management
      |Management
    • Chest Pain Guidelines
    • Compensation
    • Economics
    • Education & Training
    • Legal News
    • Patient Care
    • Policy & Regulations
    • Professional Associations
    • Quality
    • Revenue
    • Staffing
  • Technology
      |Technology
    • AI
    • Cardiac Imaging
    • Cath Lab
    • CT
    • CVIS
    • ECG
    • Echo
    • EP Lab
    • Informatics
    • MRI
    • Nuclear Cardiology
    • Remote Monitoring
  • Videos
  • Conferences
      |Conferences
    • ACC
    • AHA
    • ASE
    • ASNC
    • ESC
    • EuroPCR
    • HFSA
    • HRS
    • HRS
    • SCAI
    • SCCT
    • SIIM
    • SNMMI
    • STS
    • TCT
    • VIVA
  • Custom Content
      |Custom Content
    • Experience Stories
    • Webinars & Videos
  • Subscribe
  • Forty Under 40 Award
      |Forty Under 40 Award
    • Class of 2026
    • Class of 2025

Search form

Home

News You Need to Know Today
TAVR: How 5-year outcomes compare to surgery | Hydra THV after 1 year | AECG monitoring
Friday, January 14, 2022
Link to Twitter Link to Facebook Link to Linkedin Link to Vimeo

Editor's Choice: TAVR

TAVR and surgery tied to similar 5-year outcomes

Researchers examined data from four different randomized control trials.

READ MORE >
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Share on Twitter Share on Facebook Share on Linkedin

TAVR and surgery tied to similar 5-year outcomes

Share on Twitter Share on Facebook Share on Linkedin
Same-day discharge after TAVR is safe for low-risk patients, leads to considerable cost savings
Researchers examined data from four different randomized control trials.
READ MORE >

Hydra THV associated with promising TAVR outcomes after 1 year

Researchers reported "significant improvements" in patients after one year. 

READ MORE >
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Share on Twitter Share on Facebook Share on Linkedin

Hydra THV associated with promising TAVR outcomes after 1 year

Share on Twitter Share on Facebook Share on Linkedin
With advances and increased experience in the percutaneous coronary intervention (PCI), same-day discharge (SDD) has become increasingly commonplace, but patient selection is key. Antithrombotic therapy may not be necessary for certain transcatheter aortic valve replacement (TAVR) patients, according to a new analysis published in JACC: Cardiovascular Interventions.
Researchers reported "significant improvements" in patients after one year. 
READ MORE >

AECG monitoring helps identify when TAVR patients may require a permanent pacemaker

Post-TAVR high-degree atrioventricular block and complete heart block often lead to the implantation of a permanent pacemaker.

READ MORE >
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Share on Twitter Share on Facebook Share on Linkedin

AECG monitoring helps identify when TAVR patients may require a permanent pacemaker

Share on Twitter Share on Facebook Share on Linkedin
Large peridevice leaks after left atrial appendage occlusion (LAAO) are incredibly rare and not associated with a greater risk of adverse outcomes, according to new research published in JACC: Clinical Electrophysiology.[1] Smaller residual links are more common, however, and associated with a risk of thromboembolic and bleeding events.
Post-TAVR high-degree atrioventricular block and complete heart block often lead to the implantation of a permanent pacemaker.
READ MORE >

Self-expanding TAVR system gains approval for high-risk patients in China

The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.

READ MORE >
approved approval safe
Share on Twitter Share on Facebook Share on Linkedin

Self-expanding TAVR system gains approval for high-risk patients in China

Share on Twitter Share on Facebook Share on Linkedin
approved approval safe
The National Medical Products Administration reviewed data from more than 32,000 patients to make its decision.
READ MORE >

What happens when TAVR patients also require a peripheral vascular intervention

It does increase certain risks, researchers found—but it can also be a valuable treatment option. 

READ MORE >
IVUS guidance during DES implantation boosts long-term outcomes in new study
Share on Twitter Share on Facebook Share on Linkedin

What happens when TAVR patients also require a peripheral vascular intervention

Share on Twitter Share on Facebook Share on Linkedin
IVUS guidance during DES implantation boosts long-term outcomes in new study
It does increase certain risks, researchers found—but it can also be a valuable treatment option. 
READ MORE >

In Case You Missed It

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization. 

READ MORE >
image order
Share on Twitter Share on Facebook Share on Linkedin

Pre-TAVR pulmonary artery dilatation helps identify high-risk patients

Share on Twitter Share on Facebook Share on Linkedin
image order
Imaging-based PAD may provide value as a noninvasive alternative to right heart catheterization. 
READ MORE >

Certain patients with chronic kidney disease face a higher risk of death after TAVR

No such trend was reported among patients with end-stage kidney disease.

READ MORE >
Share on Twitter Share on Facebook Share on Linkedin

Certain patients with chronic kidney disease face a higher risk of death after TAVR

Share on Twitter Share on Facebook Share on Linkedin
No such trend was reported among patients with end-stage kidney disease.
READ MORE >

Innovate Healthcare thanks our partners for supporting our newsletters.
Sponsorship has no influence on editorial content.

Interested in reaching our audiences, contact our team

*|LIST:ADDRESSLINE|*

You received this email because you signed up for newsletters from Innovate Healthcare.
Change your preferences or unsubscribe here

Contact Us  |  Unsubscribe from all  |  Privacy Policy

© Innovate Healthcare, a TriMed Media brand
Innovate Healthcare

Recent Newsletters

AI is gaining ground, but clinicians run the show | Siemens Healthineers doubles down | Electrophysiologist compensation
News Alert: FDA shares warning about heart valve tech after patient death
Cardiologist pay & productivity are up | FDA clears PE thrombectomy devices | Cardiology tech in spotlight | Gore's new approval
Cardiology salaries on the rise | The climbing costs of care | M&A trends | Siemens Healthineers, J&J make big business moves
Major MRI trends | Blood thinner recalled | When to perform PCI before TAVR | How to build a CCTA program | Steroids & the heart
CMS boosts coverage for heart failure tech | FDA approves CardioMEMS updates | LVADs linked to strokes, other risks
M&A activity in cardiology: Exploring key trends | Cardiac PET vs. SPECT | Doctors support Medicare covering TAVR for AR
Newsletter archive
  • Home
  • News
  • Article Archive
  • Custom Content
  • Webinars
  • Press Releases
  • Content Studio
  • Advertising
  • Submit Press Release
  • Contact Us
  • Terms of Use
  • Privacy Policy
  • Cardiovascular Business
  • HealthExec
  • Radiology Business
  • Press Releases
  • Submit Press Release
© 2026 Innovate Healthcare | All Rights Reserved. | Terms of Use | Privacy Policy
Design by Adaptive Theme